Literature DB >> 18768980

Molecular and transmission characteristics of primary-passaged ovine scrapie isolates in conventional and ovine PrP transgenic mice.

Alana M Thackray1, Lee Hopkins, John Spiropoulos, Raymond Bujdoso.   

Abstract

A more complete assessment of ovine prion strain diversity will be achieved by complementing biological strain typing in conventional and ovine PrP transgenic mice with a biochemical analysis of the resultant PrPSc. This will provide a correlation between ovine prion strain phenotype and the molecular nature of different PrP conformers associated with particular prion strains. Here, we have compared the molecular and transmission characteristics of ovine ARQ/ARQ and VRQ/VRQ scrapie isolates following primary passage in tg338 (VRQ) and tg59 (ARQ) ovine PrP transgenic mice and the conventional mouse lines C57BL/6 (Prnp(a)), RIII (Prnp(a)), and VM (Prnp(b)). Our data show that these different genotypes of scrapie isolates display similar incubation periods of >350 days in conventional and tg59 mice. Facilitated transmission of sheep scrapie isolates occurred in tg338 mice, with incubation times reduced to 64 days for VRQ/VRQ inocula and to </=210 days for ARQ/ARQ samples. Distinct genotype-specific lesion profiles were seen in the brains of conventional and tg59 mice with prion disease, which was accompanied by the accumulation of more conformationally stable PrPSc, following inoculation with ARQ/ARQ compared to VRQ/VRQ scrapie isolates. In contrast, the lesion profiles, quantities, and stability of PrPSc induced by the same inocula in tg338 mice were more similar than in the other mouse lines. Our data show that primary transmission of different genotypes of ovine prions is associated with the formation of different conformers of PrPSc with distinct molecular properties and provide the basis of a molecular approach to identify the true diversity of ovine prion strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768980      PMCID: PMC2573291          DOI: 10.1128/JVI.01454-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  The physical basis of how prion conformations determine strain phenotypes.

Authors:  Motomasa Tanaka; Sean R Collins; Brandon H Toyama; Jonathan S Weissman
Journal:  Nature       Date:  2006-06-28       Impact factor: 49.962

2.  Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.

Authors:  Alana M Thackray; Lee Hopkins; Raymond Bujdoso
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1973-01       Impact factor: 1.311

4.  The sequential development of the brain lesion of scrapie in three strains of mice.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1968-07       Impact factor: 1.311

5.  Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent.

Authors:  A G Dickinson; V M Meikle
Journal:  Mol Gen Genet       Date:  1971

6.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

7.  Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59).

Authors:  C Cordier; A Bencsik; S Philippe; D Bétemps; F Ronzon; D Calavas; C Crozet; T Baron
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

8.  Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.

Authors:  Juan Carlos Espinosa; Olivier Andréoletti; Joaquín Castilla; María Eugenia Herva; Mónica Morales; Elia Alamillo; Fayna Díaz San-Segundo; Caroline Lacroux; Séverine Lugan; Francisco Javier Salguero; Jan Langeveld; Juan María Torres
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.

Authors:  Giovanna R Mallucci; Melanie D White; Michael Farmer; Andrew Dickinson; Husna Khatun; Andrew D Powell; Sebastian Brandner; John G R Jefferys; John Collinge
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

10.  Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy.

Authors:  Vincent Béringue; Anna Bencsik; Annick Le Dur; Fabienne Reine; Thanh Lan Laï; Nathalie Chenais; Gaëlle Tilly; Anne-Gaëlle Biacabé; Thierry Baron; Jean-Luc Vilotte; Hubert Laude
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

View more
  25 in total

Review 1.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

2.  Transmissibility of caprine scrapie in ovine transgenic mice.

Authors:  Katherine I O'Rourke; David A Schneider; Terry R Spraker; Rohana P Dassanayake; Margaret A Highland; Dongyue Zhuang; Thomas C Truscott
Journal:  BMC Vet Res       Date:  2012-04-02       Impact factor: 2.741

3.  Use of murine bioassay to resolve ovine transmissible spongiform encephalopathy cases showing a bovine spongiform encephalopathy molecular profile.

Authors:  Katy E Beck; Rosemary E Sallis; Richard Lockey; Christopher M Vickery; Vincent Béringue; Hubert Laude; Thomas M Holder; Leigh Thorne; Linda A Terry; Anna C Tout; Dhanushka Jayasena; Peter C Griffiths; Saira Cawthraw; Richard Ellis; Anne Balkema-Buschmann; Martin H Groschup; Marion M Simmons; John Spiropoulos
Journal:  Brain Pathol       Date:  2011-10-13       Impact factor: 6.508

4.  Mouse-adapted scrapie strains 139A and ME7 overcome species barrier to induce experimental scrapie in hamsters and changed their pathogenic features.

Authors:  Qi Shi; Bao-Yun Zhang; Chen Gao; Jin Zhang; Hui-Ying Jiang; Cao Chen; Jun Han; Xiao-Ping Dong
Journal:  Virol J       Date:  2012-03-09       Impact factor: 4.099

5.  Isolation of prion with BSE properties from farmed goat.

Authors:  John Spiropoulos; Richard Lockey; Rosemary E Sallis; Linda A Terry; Leigh Thorne; Thomas M Holder; Katy E Beck; Marion M Simmons
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

6.  Incubation of ovine scrapie with environmental matrix results in biological and biochemical changes of PrP(Sc) over time.

Authors:  Ben C Maddison; John Spiropoulos; Christopher M Vickery; Richard Lockey; Jonathan P Owen; Keith Bishop; Claire A Baker; Kevin C Gough
Journal:  Vet Res       Date:  2015-05-01       Impact factor: 3.683

7.  Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.

Authors:  Jean-Noël Arsac; Dominique Bétemps; Eric Morignat; Cécile Féraudet; Anna Bencsik; Denise Aubert; Jacques Grassi; Thierry Baron
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

8.  Cytosolic PrP can participate in prion-mediated toxicity.

Authors:  Alana M Thackray; Chang Zhang; Tina Arndt; Raymond Bujdoso
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Relationships between PrPSc stability and incubation time for United States scrapie isolates in a natural host system.

Authors:  Catherine E Vrentas; Justin J Greenlee; Trudy L Tatum; Eric M Nicholson
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

10.  Strain typing of classical scrapie by transgenic mouse bioassay using protein misfolding cyclic amplification to replace primary passage.

Authors:  Katy E Beck; Leigh Thorne; Richard Lockey; Christopher M Vickery; Linda A Terry; Raymond Bujdoso; John Spiropoulos
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.